By Adria Calatayud Novartis and Medicines for Malaria Venture said a new treatment for babies with malaria who weigh less than 5 kilograms showed positive efficacy and safety effects in a.
Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a new treatment for malaria-infected babies under 5 kg.The positive data come from the Phase II/III CALINA.
UK Pharmacy dean continuing work with promising anti-malarial drug lanereport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lanereport.com Daily Mail and Mail on Sunday newspapers.
Malaria is a life-threatening disease spread between humans by some types of mosquitoes that is mostly found in tropical countries. UK College of Pharmacy Dean Kip Guy, Ph.D., has researched this disease for nearly two decades. His current work is focused on researching treatments for malaria to help underserved populations, and understanding how this tropical parasitic disease is like one of Kentucky's most pressing health problems: cancer.
Medicines for Malaria Venture (MMV), a leading not-for-profit partnership dedicated to combating malaria, has today announced the appointment of Martin Fitchet MD as its new Chief Executive Officer (CEO).